Literature DB >> 1326258

Increased growth of permanent mouse fibroblasts in soft agar after transfection with hepatitis B virus DNA.

M Seifer1, W H Gerlich.   

Abstract

Previously we have shown that a nontumorigenic mouse hepatocyte line harboring simian virus 40 large tumor antigen (SV 40 TAg) could be converted to a full-malignant phenotype by transfection with HBV DNA. Using a permanent SV 40 TAg-negative mouse fibroblast cell line (LTK-), we studied whether the in vitro-oncogenicity of HBV was dependent on simultaneous expression of SV 40 TAg or not. Three fibroblast lines stably transfected by full-length HBV DNA formed four times more colonies of large size in soft agar than nontransfected LTK- cells. All three clones expressed high levels of HBx protein, but variable levels of other HBV proteins. A second type of clone that was transfected by a partial HBV genome and that expressed HBV surface but no HBx proteins, did not acquire increased growth in soft agar. These data reveal that HBV DNA can enhance malignant growth independent of SV 40 TAg and suggest that HBx protein may act as an HBV oncogene at least in vitro.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326258     DOI: 10.1007/bf01309689

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  25 in total

1.  HBx gene of hepatitis B virus induces liver cancer in transgenic mice.

Authors:  C M Kim; K Koike; I Saito; T Miyamura; G Jay
Journal:  Nature       Date:  1991-05-23       Impact factor: 49.962

2.  X antigen/antibody markers in hepadnavirus infections. Presence and significance of hepadnavirus X gene product(s) in serum.

Authors:  M A Feitelson; M M Clayton; B S Blumberg
Journal:  Gastroenterology       Date:  1990-04       Impact factor: 22.682

3.  Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication.

Authors:  R Colgrove; G Simon; D Ganem
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

4.  Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice.

Authors:  T H Lee; M J Finegold; R F Shen; J L DeMayo; S L Woo; J S Butel
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

5.  Expression pattern of the hepatitis B virus genome in transfected mouse fibroblasts.

Authors:  M Seifer; K H Heermann; W H Gerlich
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

6.  Replication of hepatitis B virus in transfected nonhepatic cells.

Authors:  M Seifer; K H Heermann; W H Gerlich
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

7.  Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice.

Authors:  F V Chisari; K Klopchin; T Moriyama; C Pasquinelli; H A Dunsford; S Sell; C A Pinkert; R L Brinster; R D Palmiter
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

8.  Hepatitis B virus X protein transactivates the long terminal repeats of human immunodeficiency virus types 1 and 2.

Authors:  M Levrero; C Balsano; G Natoli; M L Avantaggiati; E Elfassi
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

9.  Co-transcribed 3' host sequences augment expression of integrated hepatitis B virus DNA.

Authors:  A F von Loringhoven; S Koch; P H Hofschneider; R Koshy
Journal:  EMBO J       Date:  1985-01       Impact factor: 11.598

10.  The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells.

Authors:  Y Shirakata; M Kawada; Y Fujiki; H Sano; M Oda; K Yaginuma; M Kobayashi; K Koike
Journal:  Jpn J Cancer Res       Date:  1989-07
View more
  2 in total

1.  pX, the HBV-encoded coactivator, interacts with components of the transcription machinery and stimulates transcription in a TAF-independent manner.

Authors:  I Haviv; D Vaizel; Y Shaul
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

2.  The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors.

Authors:  M Doria; N Klein; R Lucito; R J Schneider
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.